Browse > Article

Closure of secundum atrial septal defect: comparison between percutaneous and surgical occlusion  

Kim, Na Yeon (Department of Pediatris, Gil Medical Center, Gachon University of Medicine)
Kwon, Hyun Jung (Department of Pediatris, Gil Medical Center, Gachon University of Medicine)
Choi, Deok Young (Department of Pediatris, Gil Medical Center, Gachon University of Medicine)
Jung, Mi Jin (Department of Pediatris, Gil Medical Center, Gachon University of Medicine)
Choi, Chang Hyu (Department of Thoracic and Cardiovascular Surgery, Gil Medical Center, Gachon University of Medicine)
Kim, Seong Ho (Department of Pediatrics, Halla General Hospital)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.5, 2007 , pp. 469-475 More about this Journal
Abstract
Purpose : This study was performed to compare the safety, efficacy and clinical results of the Amplatzer septal occluder (ASO) for closure of secundum atrial septal defect (ASD) with surgery. Methods : One hundred fifteen patients diagnosed as isolated secundum ASD in Gil Medical Center, Gachon University of Medicine from January 2000 to July 2006 were included. Seventy patients underwent surgical repair of ostium secundum ASD. Forty-five consecutive patients were treated with percutaneous closure using ASO. We compared the mortality, morbidity, hospital stay, and efficacy between two groups. Results : Male to female ratio was 1:2.4. The mean age and the size of defects were not statistically different. No mortality occurred in either group. The success rate was 97.8% in the device group and 100% in the surgical group. The overall rate of complications was higher in the surgical group than in the device group (64.0 vs. 15.6%, P<0.05). Hospital stay was shorter in the device group than in the surgical group ($4.2{\pm}1.2$ vs. $12.4{\pm}4.7days$, P<0.0001). Residual shunt rates were more frequent in the device group (8.9%) than in the surgical group (4.3%) at discharge. All residual shunts disappeared at 3 months follow-up. Conclusion : Percutaneous closure of ASD using ASO is a safe and effective alternative to surgical repair. The indications of percutaneous ASD closure with ASO would be expanded by accumulation of experiences and evolutions of device.
Keywords
Atrial septal defect; Percutaneous; Surgery;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, et al. Long term outcome after surgical repair of isolated atrial septal defect: follow up at 27 to 32 years. N Engl J Med 1990;323:1645-50   DOI   ScienceOn
2 Kalmar P, Irrgang E. Cardiac surgery in the Federal Republic of Germany during 1990: a report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 1991;39:167-9   DOI   ScienceOn
3 Prieto LR, Foreman CK, Cheatham JP, Latson LA. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard clamshell septal umbrella. Am J Cardiol 1996;78:1310-2   DOI   ScienceOn
4 Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K; Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults. J Am Coll Cardiol 2002;39:1836-44   DOI   ScienceOn
5 Meijboom F, Hess J, Szatmari A, Utents EM, McGhie J, Deckers JW, et al. Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a young age. Am J Cardiol 1993;72:1431-4   DOI   ScienceOn
6 Chan KC, Godman MJ, Walsh K, Wilson N, Redington A, Gibbs JL. Transcatheter closure of atrial septal defect and interatrail communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart 1999;82:300-6
7 Berdat PA, Chatterjee T, Pfammatter JP, Windecker S, Meier B, Carrel T. Surgical managemen of complications after closure of an atrial septal or patient foramen ovale. J Thorac Cardiovac Surg 2000;120:1034-9   DOI   ScienceOn
8 Preventza O, Sampath-Kumar S, Wasnick J, Gold JP. Late cardiac perforation following transcatheter atrial septal defect closure. Ann Thorac Surg 2004;77:1435-7.-   DOI   ScienceOn
9 Aggoun Y, Gallet B, Acar P, Pulik M, Czitrom D, Lagier A, et al. Perforation of the aorta after percutaneous closure of an atrial septal defect with acute severe hemolysis. Arch Mal Coeur Vaiss 2002;95:479-82
10 Horvath KA, Burke RP, Collins JJ Jr, Cohn LH. Surgical treatment of adult atrial septal defect: early and long term results. J Am Coll Cardiol 1992;20:1156-9   DOI
11 Masura J, Gabora P, Formanek P, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997;42:388-93   DOI
12 Choi JY. Recent advances in transcatheter treatment of congenital heart disease. Korean J Pediatr 2006;49:917-29   DOI   ScienceOn
13 Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J 2006;151:228-34   DOI   ScienceOn
14 Lim HG, Lee CH, Seo HJ, Kim CW, Kim JS. Fistula of ascending aorta and right atrium following percutaneous transcatheter atrial septal defect closure, Korean J Thorac Cardiovasc Surg 2006;39:150-3   과학기술학회마을
15 Lee HJ. Transcatheter intervention of Congenital Heart Disease: current status in Korea with special comment on the device closure of atrial septal defect. Korean Circulation J 2002;32:15-6   DOI
16 Bialkowski J, Karwot B, Szkutnik M, Sredniawa B, Chodor B, Zeifert B, et al. Comparison of heart rate variability between surgical and interventional closure of atrial septal defect in children. Am J Cardiol 2003;92:356-8   DOI   ScienceOn
17 Thompson JD, Aburawi EH, Watterson KG, Van Doorn C, Gibbs JL. Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost. Heart 2002;87:466-9   DOI
18 Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004;43:302-9   DOI   ScienceOn
19 Rome JJ, Keane JF, Perry SB, Spevak PH, Lock JE. Double-umbrella closure of atrial septal defects: initial clinical applications. Circulation 1990;82:751-8   DOI   ScienceOn
20 Formigari R, Di Donato RM, Mazzera E, Carotti A, Rinelli G, Parisi F, et al. Minimally invasive or interventional repair of atrial septal defects in children: experience in 171 cases and comparison with conventional strategies. J Am Coll Cardiol 2001;37:1707-12   DOI   ScienceOn
21 Kirklin JW, Barrat-Boyes BG. Cardiac surgery 2nd edition 1993 New York: Churchill Livingstone:609-44
22 Marcus WR, Christoph K, Hans-Jurgen R, Hintereder G, Hafner G, Meyer J. Clinical investigation: valvular and congenital heart disease, nickel relase after implantation of the Amplatzer occluder, Am Heart J 2003;145:737-41   DOI   ScienceOn
23 Rome JJ. Pediatric interventional catheterization: reasonable expectations and outcomes. Pediatr Clin North Am 2004; 51:1589-610   DOI   ScienceOn
24 Bialkowski J, Karwot B, Szkutnik M. Closure of atrial septal defects in children: Surgery versus amplatzer device implantation. Tex Heart Inst J 2004;31:220-3
25 Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-5   DOI   ScienceOn
26 Chun DS, Turrentine MW, Moustapha A, Hoyer MH. Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder. Catheter Cardiovasc Interv 2003;58:246-51   DOI   ScienceOn
27 Hoffman JI, Christianson R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J. Cardiol 1978;42:641-7   DOI   ScienceOn
28 Lopez K, Dalvi BV, Balzer D, Bass JL, Momenah T, Hijazi ZM., et al. Transcatheter closure of large secundum atrial septal defects using the 40 mm Amplatzer septal occluder: results of an international registry. Catheter Cardiovasc Interv 2005;66:580-4   DOI   ScienceOn
29 Rigby ML. The era of transcatheter closure of atrial septal defects. Heart 1999;81:227-8
30 Jo SS, Han SJ, Jung MJ, Lee SJ, Seol KH, Kim GH, et al. Transcatheter closure of atrial septal defect using amplatzer septal occluder. Korean Circulation J 2002;32:17-24   DOI
31 Berger F, Vogel M, Alexi-Meskishvili V, Lange PE. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 1999;118:674-80   DOI   ScienceOn
32 Galal MO, Wobst A, Halees Z. Peri-operative complications following surgical closure of atrial septal defect type II in 232 patients: a baseline study. Eur Heart J 1994;15:1381-4   DOI
33 Berger F, Ewert P, Bjornstad PG, Dahnert I, Krings G, Brilla-Austenat I, et al. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer septal occluder. Cardiol Young 1999;9:468-73
34 Bourdages M, Piette E, Dahdah N, Miro J. Incidence of headaches after ASD percutaneous catheter closure with Amplatzer device (abstract). Catheter Cardiovasc Interv 2002;7:106
35 King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 1976;235:2506-9   DOI
36 Choi JY. Recent advances in transcatheter treatment of congenital heart disease. Korean J Pediatr 2006;49:917-29   DOI   ScienceOn